Dham S K, Anand A C, Dhananjayan G, Shetty K J
PMO, Western Air Command, C/o 56. APO.
Reader, Dept of Medicine, Armed Forces Medical College, Pune 411 040.
Med J Armed Forces India. 1995 Oct;51(4):247-250. doi: 10.1016/S0377-1237(17)30984-X. Epub 2017 Jun 26.
Eighty patients with various thyroid disorders and 20 controls were investigated to determine antibodies against thyroglobulin and microsomal antigens by haemagglutination and immunofluorescent techniques. They were also tested for immunoglobulin profile by radial immunodiffusion methods. Patients with Hashimoto's disease, idiopathic hypothyroidism, and Grave's disease showed significant elevations of IgG. None of the patients with toxic nodular goitre or thyroid adenoma showed any thyroid antibodies while 69.2% patients with Grave's disease, 16% with euthyroid goitre, 58.3% with hypothyroidism and all the patients with Hashimoto's disease had microsomal antibodies by immunofluorescent test. Similarly, all the cases of Hashimoto's disease, 41.6% of those with hypothyroidism, 30% of Grave's disease patients and none of the patients with toxic nodule or thyroid adenoma had thyroglobulin antibodies by haemaglutination test. Evaluation for auto-antibodies may aid the clinician in the overall assessment of various thyroid disorders.
对80例患有各种甲状腺疾病的患者和20例对照者进行了研究,采用血凝和免疫荧光技术检测抗甲状腺球蛋白和微粒体抗原的抗体。还通过放射免疫扩散法检测了他们的免疫球蛋白谱。桥本氏病、特发性甲状腺功能减退症和格雷夫斯病患者的IgG显著升高。毒性结节性甲状腺肿或甲状腺腺瘤患者均未显示任何甲状腺抗体,而通过免疫荧光试验,69.2%的格雷夫斯病患者、16%的甲状腺功能正常的甲状腺肿患者、58.3%的甲状腺功能减退症患者以及所有桥本氏病患者均有微粒体抗体。同样,通过血凝试验,所有桥本氏病病例、41.6%的甲状腺功能减退症患者、30%的格雷夫斯病患者以及毒性结节或甲状腺腺瘤患者均无甲状腺球蛋白抗体。自身抗体的评估可能有助于临床医生对各种甲状腺疾病进行全面评估。